Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GC1111”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)UnknownNCT02663024
What this trial is testing

Study of Idursulfase-beta (GC1111) in Hunter Syndrome

Who this might be right for
Mucopolysaccharidosis II
Green Cross Corporation 20
Testing effectiveness (Phase 2)Study completedNCT01301898
What this trial is testing

To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients

Who this might be right for
Mucopolysaccharidosis II
Green Cross Corporation 31
Large-scale testing (Phase 3)Study completedNCT03920540
What this trial is testing

GC1111 in Hunter Syndrom Patients

Who this might be right for
Hunter Syndrome
Green Cross Corporation 32
Large-scale testing (Phase 3)Study completedNCT01645189
What this trial is testing

Safety and Efficacy of Hunterase

Who this might be right for
Hunter Syndrome
Green Cross Corporation 6
Large-scale testing (Phase 3)Study completedNCT07344376
What this trial is testing

An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)

Who this might be right for
MPS IIHunter Syndrome (MPS II)Hunter Syndrome+2 more
GC Biopharma Corp 30